Literature DB >> 3018707

The receptors of the VIP family peptides (VIP, secretin, GRF, PHI, PHM, GIP, glucagon and oxyntomodulin). Specificities and identity.

G Rosselin.   

Abstract

A model is proposed for the receptors of the VIP family peptides including a ligand and a cellular domain. Specificities of the receptors are due to different ligand binding sites. Three subgroups of the family can be distinguished accordingly: glucagon and oxyntomodulin; GIP; VIP, secretin r and hGRF, PHI and PHM. In the same species, the expression of these different sites is cell-specific resulting in a stoichiometry of the ligand-receptor interaction which is compatible with physiological regulation of cell function. Specificities of the interaction as studied by native and synthetic analogs is supported both by restricted sequences of amino acids (such as that including the N-terminal histidine residue), and membrane-induced configuration of the ligand. Identity of the receptors is related to their interactions with subunits of the adenylate cyclase system. Arguments are put forward indicating that the alpha subunit of the guanyl regulatory protein is a reasonable candidate for directly transducing to the adenylyl cyclase the information contained in the activated ligand-binding site subunits. Evidence of functional and molecular heterogeneity of the recognizing site and of the alpha subunits leads to the supposition that some types of specific complementarity is retained at this level of interaction, further enhancing the possibility of species and cell differences. On the other hand, the identities found in other sequences of the alpha and ras oncogene products extend to the receptor of the VIP family peptides a pattern of organization which is similar to that recently described for the insulin family of receptors. The role of ligand specific receptor mediated regulation in homologous or heterologous desensitization is reviewed in brief for the peptides of the VIP family as well as the appearance of the specific receptor during the ontogenesis or the cell differentiation. The co-distribution of plasma membrane receptors from other families further adds to the cell specificity resulting for each differentiated cell in unique patterns of recognizing site. Some examples of receptor-receptor interaction are given, indicating that the integration of the different signals by cells might occur at an early step through the transmembranair domain of the receptor.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3018707     DOI: 10.1016/0196-9781(86)90170-1

Source DB:  PubMed          Journal:  Peptides        ISSN: 0196-9781            Impact factor:   3.750


  7 in total

1.  Localisation and characterisation of functional vasoactive intestinal peptide receptors in feline kidney.

Authors:  N M Griffiths; N L Simmons
Journal:  Pflugers Arch       Date:  1990-04       Impact factor: 3.657

2.  Predominant expression of type II vasoactive intestinal peptide receptors by human T lymphoblastoma cells: transduction of both Ca2+ and cyclic AMP signals.

Authors:  M Xia; S P Sreedharan; E J Goetzl
Journal:  J Clin Immunol       Date:  1996-01       Impact factor: 8.317

3.  Effect of vasoactive intestinal polypeptide on the release of serotonin from the in vitro vascularly perfused small intestine of guinea pig.

Authors:  H Schwörer; K Racké; H Kilbinger
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-05       Impact factor: 3.000

4.  Receptor binding of guinea pig and pig vasoactive intestinal peptides by rat lung.

Authors:  S Paul; D J Volle; J Currie
Journal:  Biochem J       Date:  1988-09-01       Impact factor: 3.857

5.  Vasoactive intestinal polypeptide modulation of nicotinic ACh receptor channels in rat intracardiac neurones.

Authors:  J Cuevas; D J Adams
Journal:  J Physiol       Date:  1996-06-01       Impact factor: 5.182

6.  Characterization of normal breast epithelial cells in primary cultures: differentiation and growth factor receptors studies.

Authors:  P Berthon; G Pancino; P de Cremoux; A Roseto; C Gespach; F Calvo
Journal:  In Vitro Cell Dev Biol       Date:  1992 Nov-Dec

7.  Molecular cloning and expression of a cDNA encoding the secretin receptor.

Authors:  T Ishihara; S Nakamura; Y Kaziro; T Takahashi; K Takahashi; S Nagata
Journal:  EMBO J       Date:  1991-07       Impact factor: 11.598

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.